CEO Ron Squarer sold 819,671 shares of ARRY stock on 12/19/2017 at the average price of $10.86. The price of the stock has increased by 0.09% since. Directors and Officers Recent Trades: COO Andrew R Robbins sold 282,874 shares of …
The 2024 Notes, any shares of common stock issuable upon conversion of the ... The post Array BioPharma Inc. (NASDAQ:ARRY) Files An 8-K Entry into a Material Definitive Agreement appeared first on Market Exclusive.
Array BioPharma Inc. ARRY was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the …
Investors in Array BioPharma Inc. ARRY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2017 $5.00 Put had some of the highest implied volatility of all equity options today. …
Investors in Array BioPharma Inc. ARRY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2017 $5.00 Put had some of the highest implied volatility of all equity options today. …
Array BioPharma (ARRY) needs investors to pay close attention to the stock based on moves in the options market lately.